NCT02016183 Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months) Status COMPLETED Phase N/A
NCT02015780 Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis Status WITHDRAWN Phase PHASE3
NCT02003014 Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment" Status COMPLETED Phase N/A
NCT02002975 Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus" Status COMPLETED Phase N/A
NCT02001857 Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. Status COMPLETED Phase PHASE4
NCT01993927 Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance" Status COMPLETED Phase N/A
NCT01993875 Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation Status COMPLETED Phase PHASE3
NCT01990339 Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms Status COMPLETED Phase N/A
NCT01990300 Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT01972724 Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy Status COMPLETED Phase PHASE4
NCT01967264 Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults Status COMPLETED Phase PHASE1
NCT01967251 Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction Status WITHDRAWN Phase PHASE2
NCT01964976 Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides Status COMPLETED Phase N/A
NCT01964963 Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT01964950 Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea Status COMPLETED Phase N/A
NCT01953081 A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance Status COMPLETED Phase PHASE1/PHASE2
NCT01945242 Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones" Status COMPLETED Phase N/A
NCT01945216 Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI" Status COMPLETED Phase N/A
NCT01931566 Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset Status TERMINATED Phase PHASE3